<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37486790</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>229</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Within-Host Rhinovirus Evolution in Upper and Lower Respiratory Tract Highlights Capsid Variability and Mutation-Independent Compartmentalization.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>412</EndPage><MedlinePgn>403-412</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiad284</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rhinovirus (RV) infections can progress from the upper (URT) to lower (LRT) respiratory tract in immunocompromised individuals, causing high rates of fatal pneumonia. Little is known about how RV evolves within hosts during infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We sequenced RV complete genomes from 12 hematopoietic cell transplant patients with infection for up to 190 days from both URT (nasal wash, NW) and LRT (bronchoalveolar lavage, BAL). Metagenomic and amplicon next-generation sequencing were used to track the emergence and evolution of intrahost single nucleotide variants (iSNVs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Identical RV intrahost populations in matched NW and BAL specimens indicated no genetic adaptation is required for RV to progress from URT to LRT. Coding iSNVs were 2.3-fold more prevalent in capsid over nonstructural genes. iSNVs modeled were significantly more likely to be found in capsid surface residues, but were not preferentially located in known RV-neutralizing antibody epitopes. Newly emergent, genotype-matched iSNV haplotypes from immunocompromised individuals in 2008-2010 could be detected in Seattle-area community RV sequences in 2020-2021.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">RV infections in immunocompromised hosts can progress from URT to LRT with no specific evolutionary requirement. Capsid proteins carry the highest variability and emergent mutations can be detected in other, including future, RV sequences.</AbstractText><CopyrightInformation>© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makhsous</LastName><ForeName>Negar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goya</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avendaño</LastName><ForeName>Carlos C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rupp</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuypers</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerome</LastName><ForeName>Keith R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeckh</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waghmare</LastName><ForeName>Alpana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greninger</LastName><ForeName>Alexander L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-7443-0527</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AI114844</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI153087</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI114844-02</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 May 11:2023.05.11.540440. doi: 10.1101/2023.05.11.540440</RefSource><PMID Version="1">37214809</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RV</Keyword><Keyword MajorTopicYN="N">genome</Keyword><Keyword MajorTopicYN="N">human rhinovirus</Keyword><Keyword MajorTopicYN="N">iSNV</Keyword><Keyword MajorTopicYN="N">immunocompromised</Keyword><Keyword MajorTopicYN="N">intrahost single-nucleotide variants</Keyword><Keyword MajorTopicYN="N">metagenomics</Keyword><Keyword MajorTopicYN="N">within-host evolution</Keyword></KeywordList><CoiStatement>Potential conflicts of interest . A. L. G. reports contract testing from Abbott, Cepheid, Novavax, Pfizer, Janssen, and Hologic; and research support from Gilead and Merck, outside of the described work. A. W. reports research support from Pfizer, Amazon, GlaxoSmithKline/Vir, Ansun Biopharma, and Allovir; receiving personal fees from Kyorin Pharmaceutical and Vir Biotechnology; and receiving grants from Amazon and VB Tech, all outside the submitted work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>19</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37486790</ArticleId><ArticleId IdType="pmc">PMC10873175</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiad284</ArticleId><ArticleId IdType="pii">7229966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bernard NF, Knipe DM, Howley PM. Fields virology. Philadelphia, PA: Lippincott Williams &amp; Wilkins, 2013.</Citation></Reference><Reference><Citation>George SN, Garcha DS, Mackay AJ, et al. . Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 2014; 44:87–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">24627537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev 2013; 26:135–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare A, Xie H, Kuypers J, et al. . Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection. Biol Blood Marrow Transplant 2019; 25:1011–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511300</ArticleId><ArticleId IdType="pubmed">30537551</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Lamson DM, Soave R, et al. . Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy. J Clin Virol 2015; 71:51–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750469</ArticleId><ArticleId IdType="pubmed">26370315</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs SE, Soave R, Shore TB, et al. . Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2013; 15:474–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962254</ArticleId><ArticleId IdType="pubmed">23890179</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S, Waghmare A, Scott EM, et al. . Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality. Haematologica 2017; 102:1120–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451345</ArticleId><ArticleId IdType="pubmed">28183847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ison MG, Hayden FG, Kaiser L, Corey L, Boeckh M. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 2003; 36:1139–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109670</ArticleId><ArticleId IdType="pubmed">12715308</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre CL, Knowles NJ, Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol 2013; 94:1791–806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3749525</ArticleId><ArticleId IdType="pubmed">23677786</ArticleId></ArticleIdList></Reference><Reference><Citation>Golke P, Hönemann M, Bergs S, Liebert UG. Human rhinoviruses in adult patients in a tertiary care hospital in Germany: molecular epidemiology and clinical significance. Viruses 2021; 13:2027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8539166</ArticleId><ArticleId IdType="pubmed">34696457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Simpson AA, Ledford RM, et al. . Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. J Virol 2004; 78:11061–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521849</ArticleId><ArticleId IdType="pubmed">15452226</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlateva KT, de Vries JJC, Coenjaerts FEJ, et al. . Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness. Eur Respir J 2014; 44:169–77.</Citation><ArticleIdList><ArticleId IdType="pubmed">24876172</ArticleId></ArticleIdList></Reference><Reference><Citation>Giardina FAM, Piralla A, Ferrari G, Zavaglio F, Cassaniti I, Baldanti F. Molecular epidemiology of rhinovirus/enterovirus and their role on cause severe and prolonged infection in hospitalized patients. Microorganisms 2022; 10:755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9030097</ArticleId><ArticleId IdType="pubmed">35456806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenmoe S, Sadeuh-Mba SA, Vernet M-A, Penlap Beng V, Vabret A, Njouom R. Molecular epidemiology of enteroviruses and rhinoviruses in patients with acute respiratory infections in Yaounde, Cameroon. Influenza Other Respir Viruses 2021; 15:641–50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404047</ArticleId><ArticleId IdType="pubmed">33694322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai J, Zhu Y, Duan Y, et al. . A multicenter study on molecular epidemiology of rhinovirus isolated from children with community acquired pneumonia in China during 2017–2019. Infect Genet Evol 2022; 106:105384.</Citation><ArticleIdList><ArticleId IdType="pubmed">36396029</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger AL, Waghmare A, Adler A, et al. . Rule-out outbreak: 24-hour metagenomic next-generation sequencing for characterizing respiratory virus source for infection prevention. J Pediatr Infect Dis Soc 2017; 6:168–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5907853</ArticleId><ArticleId IdType="pubmed">28379561</ArticleId></ArticleIdList></Reference><Reference><Citation>Iketani S, Shean RC, Ferren M, et al. . Viral entry properties required for fitness in humans are lost through rapid genomic change during viral isolation. mBio 2018; 9:e00898-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030562</ArticleId><ArticleId IdType="pubmed">29970463</ArticleId></ArticleIdList></Reference><Reference><Citation>
International Committee on Taxonomy of Viruses . Family: picornaviridae. https://ictv.global/report/chapter/picornaviridae/picornaviridae/enterovirus. Accessed 15 June 2023.</Citation></Reference><Reference><Citation>Minh BQ, Schmidt HA, Chernomor O, et al. . IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 2020; 37:1530–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182206</ArticleId><ArticleId IdType="pubmed">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang DT, Chernomor O, von Haeseler A, Minh BQ, Vinh LS. UFBoot2: improving the ultrafast bootstrap approximation. Mol Biol Evol 2018; 35:518–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850222</ArticleId><ArticleId IdType="pubmed">29077904</ArticleId></ArticleIdList></Reference><Reference><Citation>Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010; 59:307–21.</Citation><ArticleIdList><ArticleId IdType="pubmed">20525638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MJ, Shean RC, Makhsous N, Greninger AL. LAVA: a streamlined visualization tool for longitudinal analysis of viral alleles. bioRxiv, doi: 10.1101/2019.12.17.879320, 18 December2019, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2019.12.17.879320</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM.arXiv, doi: 10.48550/arXiv.1303.3997, 16 March2013, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1303.3997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol 2019; 20:257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6883579</ArticleId><ArticleId IdType="pubmed">31779668</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 2013; 8:e61217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632530</ArticleId><ArticleId IdType="pubmed">23630581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H. Ggplot2. New York, NY: Springer, 2009.</Citation></Reference><Reference><Citation>Schrödinger LLC. The PyMOL molecular graphics system, Version 1.2r3pre. Schrödinger, LLC.</Citation></Reference><Reference><Citation>Hadfield AT, Lee WM, Zhao R, et al. . The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. Structure 1997; 5:427–41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9083115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattenberger F, Latorre V, Tirosh O, Stern A, Geller R. Globally defining the effects of mutations in a picornavirus capsid. eLife 2021;10:e64256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861617</ArticleId><ArticleId IdType="pubmed">33432927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry B, Mosser AG, Colonno RJ, Rueckert RR. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 1986; 57:246–57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC252721</ArticleId><ArticleId IdType="pubmed">2416951</ArticleId></ArticleIdList></Reference><Reference><Citation>Appleyard G, Russell SM, Clarke BE, Speller SA, Trowbridge M, Vadolas J. Neutralization epitopes of human rhinovirus type 2. J Gen Virol 1990; 71:1275–82.</Citation><ArticleIdList><ArticleId IdType="pubmed">1693662</ArticleId></ArticleIdList></Reference><Reference><Citation>Liggett SB, Bochkov YA, Pappas T, et al. . Genome sequences of rhinovirus a isolates from Wisconsin pediatric respiratory studies. Genome Announc 2014; 2:e00200-14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3968333</ArticleId><ArticleId IdType="pubmed">24675855</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow EJ, Casto AM, Roychoudhury P, et al. . The clinical and genomic epidemiology of rhinovirus in homeless shelters—King County, Washington. J Infect Dis 2022; 226:S304–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384451</ArticleId><ArticleId IdType="pubmed">35749582</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Yang T, Yang C, et al. . Molecular epidemiology and clinical characterization of human rhinoviruses circulating in Shanghai, 2012–2020. Arch Virol 2022; 167:1111–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8931777</ArticleId><ArticleId IdType="pubmed">35303167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogimi C, Xie H, Leisenring WM, et al. . Initial high viral load is associated with prolonged shedding of human rhinovirus in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2018; 24:2160–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239940</ArticleId><ArticleId IdType="pubmed">30009982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Junier T, Gerlach D, et al. . Rhinovirus genome evolution during experimental human infection. PLoS One 2010; 5:e10588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2868056</ArticleId><ArticleId IdType="pubmed">20485673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C, Cordey S, Junier T, et al. . Rhinovirus genome variation during chronic upper and lower respiratory tract infections. PLoS One 2011; 6:e21163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119694</ArticleId><ArticleId IdType="pubmed">21713005</ArticleId></ArticleIdList></Reference><Reference><Citation>Basta HA, Ashraf S, Sgro J-Y, Bochkov YA, Gern JE, Palmenberg AC. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance. Virology 2014; 448:82–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878079</ArticleId><ArticleId IdType="pubmed">24314639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford RM, Patel NR, Demenczuk TM, et al. . VP1 Sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol 2004; 78:3663–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC371056</ArticleId><ArticleId IdType="pubmed">15016887</ArticleId></ArticleIdList></Reference><Reference><Citation>Green HD, Bright-Thomas R, Kenna DT, Turton JF, Woodford N, Jones AM. Ralstonia infection in cystic fibrosis. Epidemiol Infect 2017; 145:2864–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203427</ArticleId><ArticleId IdType="pubmed">28791938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MR, Huang YT, Liao CH, et al. . Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000–2010. Eur J Clin Microbiol Infect Dis 2011; 30:1185–91.</Citation><ArticleIdList><ArticleId IdType="pubmed">21461849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W-J, Arnold JC, Fairchok MP, et al. . Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults. J Clin Virol 2015; 64:74–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4347877</ArticleId><ArticleId IdType="pubmed">25728083</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin ET, Kuypers J, Chu HY, et al. . Heterotypic infection and spread of rhinovirus A, B, and C among childcare attendees. J Infect Dis 2018; 218:848–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107396</ArticleId><ArticleId IdType="pubmed">29684211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlateva KT, van Rijn AL, Simmonds P, et al. . Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007–2010). Thorax 2020; 75:882–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7509388</ArticleId><ArticleId IdType="pubmed">32820081</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrone JT, Lauring AS. Measurements of intrahost viral diversity are extremely sensitive to systematic errors in variant calling. J Virol 2016; 90:6884–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944299</ArticleId><ArticleId IdType="pubmed">27194763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue KS, Stevens-Ayers T, Campbell AP, et al. . Parallel evolution of influenza across multiple spatiotemporal scales. eLife 2017; 6:e26875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5487208</ArticleId><ArticleId IdType="pubmed">28653624</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. J Infect Dis 1987; 156:43–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3036962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw J, Jorba J, Zhao K, et al. . Dynamics of evolution of poliovirus neutralizing antigenic sites and other capsid functional domains during a large and prolonged outbreak. J Virol 2018; 92:e01949-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899205</ArticleId><ArticleId IdType="pubmed">29444940</ArticleId></ArticleIdList></Reference><Reference><Citation>Valesano AL, Taniuchi M, Fitzsimmons WJ, et al. . The early evolution of oral poliovirus vaccine is shaped by strong positive selection and tight transmission bottlenecks. Cell Host Microbe 2021; 29:32–43.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7815045</ArticleId><ArticleId IdType="pubmed">33212020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>